Bukwang Pharmaceutical Co., Ltd. (KRX:003000)
South Korea
· Delayed Price · Currency is KRW 6,510.00
-170.00 (-2.54%)
Last updated: Apr 29, 2026, 2:04 PM KST
Bukwang Pharmaceutical Revenue
In the year 2025, Bukwang Pharmaceutical had annual revenue of 200.71B KRW with 25.38% growth. Bukwang Pharmaceutical had revenue of 62.51B in the quarter ending December 31, 2025, with 35.37% growth.
Revenue
200.71B
Revenue Growth
+25.38%
P/S Ratio
3.28
Revenue / Employee
326.36M
Employees
615
Market Cap
659.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 200.71B | 40.63B | 25.38% |
| Dec 31, 2024 | 160.09B | 34.16B | 27.13% |
| Dec 31, 2023 | 125.93B | -64.98B | -34.04% |
| Dec 31, 2022 | 190.91B | 8.42B | 4.61% |
| Dec 31, 2021 | 182.49B | 12.83B | 7.56% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JW Pharmaceutical | 775.30B |
| Huons Global | 847.45B |
| Boryung | 1,017.43B |
| Dong-A Socio Holdings | 1,429.77B |
| Ildong Pharmaceutical | 566.93B |
| Daewoong | 2,068.37B |
| Shinpoong Pharmaceutical Co.,Ltd | 234.68B |
| EuBiologics | 96.04B |